Imidazopyrimidine-based inhibitor of Leishmania proteasome identified to treat visceral leishmaniasis

DISEASE CATEGORY: Infectious disease

INDICATION: Leishmaniasis

Cell culture, in vitro, mouse, rat and dog studies identified an imidazopyrimidine-based inhibitor of Leishmania proteasome that

Read the full 218 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE